In this Section |
259028 Smoking Cessation and Reduction in Pregnancy Treatment (SCRIPT) Adoption Scale (SAS): Evaluating the Diffusion of an Tobacco Treatment Innovation to a Prenatal Care Program and ProvidersMonday, October 29, 2012
When a new patient education program is adopted by a health agency, it is essential to determine the perceptions of providers about its acceptability for routine use. In 2007 the WV Right From The Start (RFTS) Project adopted the Smoking Cessation and Reduction In Pregnancy Treatment (SCRIPT) Program. RFTS is a state-wide perinatal home visitation initiative delivered by Designated Care Coordinators (DCCs). In the absence of a valid instrument to assess the perceived attributes of a tobacco treatment innovation among the RFTS-DCC population, the SCRIPT Adoption Scale (SAS) was developed. We evaluated the validity of the five constructs of the Rogers' Diffusion of Innovation Model in an Organization to predict routine SCRIPT program use: Relative Advantage, Compatibility, Complexity, Observability, and Trialability. After reviewing the literature and developing draft SAS Forms, expert panel reviews established the face and content validity of a 43-item SAS. It was administered to 90% of the RFTS DCC population (N = 85/90). Psychometric analyses confirmed the validity and reliability of a 28-item scale. All 28 items had factor loadings of > 0.40 (0.43-0.81). All SAS sub-scales were strongly correlated, r = 0.51 to 0.97, with each other supporting the convergent validity of a five factor SAS. The internal consistency of the SAS was r = 0.93 and stability was r = 0.76. While several specific SAS sub-scales need to be improved, the SAS can be adapted by prenatal care programs to measure the attributes of adoption of new, evidence-based health education methods.
Learning Areas:
Administer health education strategies, interventions and programsBiostatistics, economics Public health or related research Learning Objectives: Keywords: Evaluation, Patient Education
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am the Principal Investigator of an NCI funded grant to conduct an effectiveness evaluation of the SCRIPT evidence-based program disseminated throughout the state of West Virginia in collaboration with the W.V. DHHS. This Project expands on my previous work in promoting smoking cessation among pregnant women, involves training public health nurses/social workers in the 5 A’s consistent with American College of Obstetricians and Gynecologists (ACOG) guidelines. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 3385.0: Triple Threat: Mixing & Matching of Alcohol, Tobacco and Other Drugs
|